Literature DB >> 1603271

[Management of elderly patients with aneurysmal subarachnoid hemorrhage].

T Yasui1, H Yagura, M Komiyama, K Tamura, Y Nagata, Y Fu, A M Kim, S Nishimura.   

Abstract

Clinical features of 61 elderly patients aged over 70 years with ruptured intracranial aneurysms were compared with those of 328 younger patients aged under 70 years. According to a policy of early operation, elderly patients with Hunt and Kosnik's grade I, II and younger patients with grade I, II, III were operated on in the acute stage. In elderly patients with grade III, IV and younger patients with grade IV, the indication for surgery was determined case by case. Surgery was performed on 29 patients (48%) in the elderly group and 277 patients (86%) in the younger group. Our conclusions are as follows: 1. Regarding cases of grade I, II and III of Hunt and Kosnik's classification, the rate of good outcome in the elderly group was similar to that in the younger group, following early surgery and meticulous post-operative care. 2. In the elderly group, no patient in cases of grade IV obtained good surgical outcome. 3. Symptomatic vasospasm was less frequent in elderly patients (18.8%) than in younger cases (37%). 4. Delayed operation was planned for some patients in the elderly group, but none of them underwent surgery because of rerupture of aneurysms and deterioration of general condition.

Entities:  

Mesh:

Year:  1992        PMID: 1603271

Source DB:  PubMed          Journal:  No Shinkei Geka        ISSN: 0301-2603


  2 in total

1.  Endovascular management of poor-grade aneurysmal subarachnoid hemorrhage in the geriatric population.

Authors:  Rajan Jain; John Deveikis; Byron Gregory Thompson
Journal:  AJNR Am J Neuroradiol       Date:  2004-04       Impact factor: 3.825

2.  Comparison of Aggressive Surgical Treatment and Palliative Treatment in Elderly Patients with Poor-Grade Intracranial Aneurysmal Subarachnoid Hemorrhage.

Authors:  Kuang Zheng; Bing Zhao; Xian-Xi Tan; Ze-Qun Li; Ye Xiong; Ming Zhong; Si-Yan Chen
Journal:  Biomed Res Int       Date:  2018-05-28       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.